About this trial
The goal of this observational study is to determine how much effect turning the subject's Gastric Electrical Stimulator off for up to four hours will have on levels of insulin, C-peptide, GLP-1 and Glucose levels in patients with gastroparesis who have had a GES for at least three months, who are not taking diabetic prescribed exogenous insulin. EKG recordings will be made and analyzed for Heart Rate Variability and Power Spectral Analysis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• At least 18 years of age.
Documented diagnosis of gastroparesis
Not taking diabetic prescribed exogenous insulin.
Patient has a GES device that has been implanted for at least 3 months.
Disqualifiers
• Pregnancy
History of allergic reaction to EKG lead placement adhesives.
Unable to give informed consent.
Unwilling to give up to 8 5 ml blood samples.
Trial design
Single group
Treatments tested in this trial
Gastric Electrical Stimulator
DeviceDevice will either be turned off for the duration of the experiment, or the device will be left on for the duration of the experiment
Treatment groups
Trial outcomes
Primary outcomes
Definition of Effect
To define the effect of prolonged four-hour withdrawal of gastric electrical stimulation on serum insulin and C-peptide levels in human subjects. Insulin and C-peptide are co-primary end points.
Secondary outcomes
Comparing Hormone Levels
To compare the changes in serum insulin and C-peptide levels after 4-hour withdrawal of gastric electrical stimulation to a control group that does not undergo withdrawal of gastric electrical stimulation.
Definition of 4-Hour Withdrawl of GES Device
To define the effect of prolonged four-hour withdrawal of gastric electrical stimulation on serum GLP-1 and glucose levels in human subjects. GLP-1 and glucose are co-secondary end points.
Changes in Glucose and GLP-1 Levels
To compare the changes in serum GLP-1 and glucose levels after 4-hour withdrawal of gastric electrical stimulation to a control group that does not undergo withdrawal of gastric electrical stimulation.
Other outcomes
Tertiary Objective
To determine whether changes noted in serum levels of insulin, C-peptide, GLP-1 and glucose are associated with alterations in heart rate variability and sympathetic and parasympathetic autonomic activation.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.